Marked Palliative Benefits Seen With Treatment of Very Advanced Breast Cancer With the Progesterone Receptor Modulator Mifepristone

JEROME H. CHECK; DIANE L. CHECK; NAOMI GANPO-NKEWNKWA

doi:10.21873/anticanres.18018

Research ArticleCase Reports

Marked Palliative Benefits Seen With Treatment of Very Advanced Breast Cancer With the Progesterone Receptor Modulator Mifepristone

JEROME H. CHECK, DIANE L. CHECK and NAOMI GANPO-NKEWNKWA

Anticancer Research February 2026, 46 (2) 1153-1165; DOI: https://doi.org/10.21873/anticanres.18018

JEROME H. CHECK

1Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Cooper Medical School, Rowan University, Camden, NJ, U.S.A.;

2Cooper Institute for Reproductive Hormonal Disorders, Mt Laurel, NJ, U.S.A.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: megan.oneil{at}ccivf.com

DIANE L. CHECK

2Cooper Institute for Reproductive Hormonal Disorders, Mt Laurel, NJ, U.S.A.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

NAOMI GANPO-NKEWNKWA

1Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Cooper Medical School, Rowan University, Camden, NJ, U.S.A.;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
PDF

Log in using your username and password

Username *

Password *

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles

PreviousNext

In this issue

Anticancer Research

Vol. 46, Issue 2

February 2026

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Ed Board (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Marked Palliative Benefits Seen With Treatment of Very Advanced Breast Cancer With the Progesterone Receptor Modulator Mifepristone

Message Subject (Your Name) has sent you a message from Anticancer Research

Message Body (Your Name) thought you would like to see the Anticancer Research web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 6 + 0 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

Marked Palliative Benefits Seen With Treatment of Very Advanced Breast Cancer With the Progesterone Receptor Modulator Mifepristone

JEROME H. CHECK, DIANE L. CHECK, NAOMI GANPO-NKEWNKWA

Anticancer Research Feb 2026, 46 (2) 1153-1165; DOI: 10.21873/anticanres.18018

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Reprints and Permissions

Marked Palliative Benefits Seen With Treatment of Very Advanced Breast Cancer With the Progesterone Receptor Modulator Mifepristone

JEROME H. CHECK, DIANE L. CHECK, NAOMI GANPO-NKEWNKWA

Anticancer Research Feb 2026, 46 (2) 1153-1165; DOI: 10.21873/anticanres.18018

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
PDF

Cited By...

No citing articles found.

Google Scholar

Keywords

Terminal breast cancer
progesterone receptor modulator
brain metastases
membrane progesterone receptor
progesterone induced blocking factor
immunomodulatory proteins

Main menu

User menu

Search

Marked Palliative Benefits Seen With Treatment of Very Advanced Breast Cancer With the Progesterone Receptor Modulator Mifepristone

Purchase access

patientACCESS

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Keywords